NASDAQ · DMAAU
Drugs Made In America Acquisition Corp. Units
Financial Services · Financial - Conglomerates
$10.99
Down-$0.01 (-0.11%)
Updated Oct 14, 2026, 10:38 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 247.19M
- P/E ratio
- 41.6
- Dividend yield
- 0.00%
- 52-week range
- $10.00 – $12.50
- Volume
- 100
- Avg. volume
- 3.17K
Price performance · DMAAU
DMAAU price history
1M range · 1 trading sessions · Daily adjusted prices
Prices through Sep 21, 2026
DMAAU closed at $10.99 after 1 trading sessions, up 0.00% for the selected period.
No results
At least two price observations are needed to draw this chart.
Latest DMAAU news
The latest Smart Investors Daily articles mentioning DMAAU.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DMAAU research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition Corp is a blank check company.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
